Clinical trial
A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
NCT00117182 is registered in ClinicalTrials.gov with Syntara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
- Lead sponsor
- Syntara
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- August 31, 2006
- Enrollment
- 140
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.